/PRNewswire/ Indivior PLC (LON: INDV) today announced that at the General Meeting of Shareholders held earlier today, shareholders approved the resolution.
Indivior plc (via Public) / Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
RICHMOND, Va., April 22, 2021 /PRNewswire/ Indivior PLC (LON: INDV) today announced findings from a qualitative study examining the impact of COVID-19 on opioid use disorder (OUD) management and medication for opioid use disorder (MOUD) access in the U.S. which found that 85% of participants agreed that patients with OUD experienced more barriers to care during the COVID-19 pandemic.
1 Results from the study, entitled Impact of COVID-19 on OUD Management and MOUD Access in the US, were presented at the American Society of Addiction Medicine (ASAM) 2021 virtual meeting. The study was conducted to understand the impact of the COVID-19 pandemic on the management of OUD in the US from both provider and payer perspectives, as well as to gain insight into strategies adopted by healthcare organizations to overcome access barriers to OUD care and MOUD.